Global study warns chronic kidney disease now affects nearly 800 million people
A sweeping global analysis has found that chronic kidney disease (CKD) affects an estimated 800 million adults worldwide. The Science Daily Health service reported on Monday that the findings show the disease 'rising into the top ten leading causes of death globally'.
The analysis, led by Massachusetts General Brigham Health and based on data from 47 countries and 1.7 million adults, lifted the global CKD prevalence rate from 8.6 percent in 2015 to 9.8 percent in 2024. Lead author Joseph Vassalotti described that 11 percent increase as 'too large to be downplayed by headline numbers'.
In a press release, Vassalotti said 'the disease's lack of early symptoms means that millions of people continue to live undiagnosed'. The study's data showed that CKD is often present 'before the starting point of treatment' alongside type 2 diabetes and hypertension.
International Society of Nephrology vice-president Vivekanand Jha, in his assessment of the study, told Science Daily that 'the rise of CKD in mortality rankings represents the globalisation of a trend that has long been observed in the Pacific islands and sub-Saharan Africa'.
The analysis used adult data from the health databases of 47 countries. Turkey's Ministry of Health database was included, with the country recording CKD prevalence at 12.4 percent — above the global average.
Joseph Coresh of Esclepia Heart Health Center, assessing the heart-disease link, said that CKD 'is an underlying factor in roughly one third of cardiovascular deaths'. Coresh added that the three-year data on GLP-1 and SGLT2-inhibitor class drugs slowing CKD progression were 'a promising development'.
Mahboob Rahman of the Cleveland Clinic, who had methodological reservations, told Science Daily that 'global databases using different CKD diagnostic criteria limit accurate prevalence calculation'. Rahman noted that the ISN is planning to publish a new guideline for the global CKD definition in 2027.
Kidney Care UK director Fiona Loud told Science Daily that 'an estimated 8 million adults in the United Kingdom are living with CKD and around 60 percent of them are formally undiagnosed'. Loud said that routine screening in NHS primary care was 'an opportunity for early intervention'.
World Health Organization non-communicable diseases director Bente Mikkelsen said in a statement from Geneva that 'CKD is an under-recognised disease on global health priority lists; this study calls for the WHO to reassess its funding distribution'. Mikkelsen announced that CKD would receive 'global priority disease status' in 2027.
Turkish Society of Nephrology president Mehmet Tonbul, on the situation in Turkey, told Science Daily that 'the current number of nephrology specialists is not sufficient to bear the global CKD burden'. Tonbul said that the Ministry of Health was planning to launch a 250-specialist nephrology training programme by the end of 2026. This article is not personal medical advice; speak to your health-care provider about kidney health.
Read next
World's largest opioid review finds they often do not work
The largest review yet of opioid use in chronic pain has concluded that the drugs often deliver disappointing results across many clinical situations, Science Daily reports. The researchers say prescribing practices should be revisited.
Doctors and the NHS could be sued for mistakes made by AI tools, report warns
According to the Guardian, a new Medical Protection Society report finds that doctors and NHS services could be sued over mistakes made by AI tools used in clinical practice. The report calls for an urgent update to insurance and liability frameworks.
Tea benefits your health and longevity — how you drink it matters
A new international study reported by Science Daily finds regular tea drinking may reduce cardiovascular risk and all-cause mortality. The researchers stress, however, that the effect depends on daily dose, preparation style and whether you add milk or sugar.
Weight-loss drugs drive global whey protein supply toward shortage
Global demand for whey protein is hitting record levels as millions of patients on GLP-1 weight-loss drugs turn to high-protein diets to offset muscle loss, the Guardian reports. Suppliers say production capacity is already pushed close to its limits.
FDA approves first new sunscreen ingredient in over 25 years
The US Food and Drug Administration has cleared bemotrizinol, a broad-spectrum UVA-UVB filter long used in Europe, for the American market. As reported by STAT News, it is the first new sunscreen active ingredient to receive FDA approval since 1999.
